title: Pleuroparenchymal fibroelastosis: one more walk on the wild side of drugs?
authors.affiliation: Dept of Pulmonary Medicine and Intensive Care, Centre Hospitalier Universitaire Le Bocage, Dijon, France Faculté de Médecine, Université de Bourgogne, Dijon, France ph.camus@chu-dijon.fr.
authors.forename: Philippe
authors.initials: P
authors.lastname: Camus
authors.affiliation: Dept of Pathology, Medisch Centrum Haaglanden, Den Haag, The Netherlands.
authors.forename: Jan
authors.initials: J
authors.lastname: von der Thüsen
authors.affiliation: Dept of Thoracic Imaging, National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
authors.forename: David M
authors.initials: DM
authors.lastname: Hansell
authors.affiliation: Dept of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA.
authors.forename: Thomas V
authors.initials: TV
authors.lastname: Colby
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008168:Lung / Q000187:drug effects*; D008297:Male; D011658:Pulmonary Fibrosis / Q000503:physiopathology*
chemical_list: D000970:Antineoplastic Agents